Liminatus Pharma, Inc.: which funds bought and sold

Institutions that bought and sold Liminatus Pharma shares in Q2 2026, from the holdings they reported to the SEC on Form 13F for March 31, 2026 and June 30, 2026.

Between March 31, 2026 and June 30, 2026, 5 institutions that filed 13F reports for both quarters added to or opened positions in Liminatus Pharma, and 10 cut or closed them. Together they sold a net 509K shares, −45.2% on what they held at the start of the quarter. Active managers and hedge funds on our list were net sellers of 621K shares (−91.7%); index fund managers were net sellers of 14K shares (−5.4%). 4 opened a new position and 5 sold out entirely.

Bought, Q2 2026 5 institutions, 4 of them new holders Sold, Q2 2026 10 institutions, 5 of them sold out

Net change, all compared −509K shares (−45.2%)

Net change, active managers −621K shares (−91.7%), 0 bought, 1 sold

Buyers versus sellers

institutions compared, 18

5 bought 3 10 sold

Active managers and hedge funds 0 bought · 1 sold · −621K

Index fund managers 1 bought · 2 sold · −14K

Other institutions 4 bought · 7 sold · +126K

Biggest buyers

by change in shares held

Biggest buyers
Institution	Change in shares	Shares June 30, 2026	Value
Xtx Topco Ltd	+222K New position	222K	$24,491
Goldman Sachs Group Inc	+40K New position	40K	$4,440
Stonex Group Inc.	+26K New position	26K	$3,934
Geode Capital Management, LLC Index funds	+21K +17.5%	138K	$15,282
Barclays PLC	+4,290 New position	4,290	$474

Biggest buyers, active managers and hedge funds
Institution	Change in shares	Shares June 30, 2026	Value
None of the active managers on our list.

Biggest sellers

by change in shares held

Biggest sellers
Institution	Change in shares	Shares June 30, 2026	Value
Citadel Advisors LLC Hedge fund	−621K −91.7%	56K	$6,192
Jane Street Group, LLC	−71K Sold out	0	—
UBS Group AG	−38K −69.3%	17K	$1,840
Virtu Financial LLC	−27K Sold out	0	—
Two Sigma Securities, LLC	−22K Sold out	0	—
Vanguard Personalized Indexing Management, LLC Index funds	−22K −62.1%	13K	$1,452
Blackrock, Inc. Index funds	−13K −97.6%	313	$35
Citigroup Inc	−6,769 Sold out	0	—
Tower Research Capital LLC (TRC)	−474 −6.3%	7,093	$783
Farther Finance Advisors, LLC	−14 Sold out	0	—

New positions

largest by value

Institution	Shares	Value June 30, 2026
Xtx Topco Ltd	222K	$24,491
Goldman Sachs Group Inc	40K	$4,440
Stonex Group Inc.	26K	$3,934
Barclays PLC	4,290	$474

Sold out

largest by value

Institution	Shares	Value March 31, 2026
Jane Street Group, LLC	71K	$12,259
Virtu Financial LLC	27K	$5,000
Two Sigma Securities, LLC	22K	$3,789
Citigroup Inc	6,769	$1,164
Farther Finance Advisors, LLC	14	$2

Who holds the shares

13F holdings at June 30, 2026

Institutions reporting: 13
Ten largest holders: 98.1%
Index fund managers: 39.6%
Active managers and hedge funds: 9.1%

Buying and selling by type of institution, March 31, 2026 to June 30, 2026
Type	Bought	Sold	New	Sold out	Net change in shares	Net %
Active managers and hedge funds	0	1	0	0	−621K	−91.7%
Index fund managers	1	2	0	0	−14K	−5.4%
Other institutions	4	7	4	5	+126K	+66.7%

Active managers and hedge funds: a list we maintain of about 400 well-known stock-picking firms and hedge funds, matched by SEC registration number (CIK) and checked against the filer names each quarter. Index fund managers: the large index houses, such as BlackRock, Vanguard, State Street, Geode and Northern Trust. Every other filer (banks, brokers, wealth managers, pension funds, insurers and firms not on the list) counts as another institution. A firm that files under several SEC registrations appears once for each.

What these filings can and cannot tell you

Form 13F lists the long positions in US-listed shares held by investment managers with more than $100 million in such holdings. Managers file it up to 45 days after each quarter ends, so this page shows what funds held at the end of each quarter, not what they are doing now: a position may have changed since. Short positions, most derivatives and smaller managers are not included, and a cut can mean a fund lost clients or rebalanced rather than a view on Liminatus Pharma.

Only managers that filed a holdings report for both quarters are compared (18 here). 1 other holder is left out: first-time or late filers, firms that changed their SEC registration, and filings that withheld positions under confidential treatment, any of which would otherwise look like a new position or a sale. Figures are as reported by each manager in the SEC's quarterly 13F data sets; option positions are excluded.

← Back to Liminatus Pharma, Inc. · Insiders · Politicians